DK141967C - Analogifremgangsmaade til fremstilling af spirolactoner - Google Patents

Analogifremgangsmaade til fremstilling af spirolactoner

Info

Publication number
DK141967C
DK141967C DK508077A DK508077A DK141967C DK 141967 C DK141967 C DK 141967C DK 508077 A DK508077 A DK 508077A DK 508077 A DK508077 A DK 508077A DK 141967 C DK141967 C DK 141967C
Authority
DK
Denmark
Prior art keywords
spirolactones
preparation
analogy procedure
analogy
procedure
Prior art date
Application number
DK508077A
Other languages
Danish (da)
English (en)
Other versions
DK508077A (da
DK141967B (da
Inventor
R Wiechert
D Bittler
U Kerb
J Casals-Stenzel
W Losert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5993550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK141967(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK508077A publication Critical patent/DK508077A/da
Priority to DK454278A priority Critical patent/DK142951C/da
Publication of DK141967B publication Critical patent/DK141967B/da
Application granted granted Critical
Publication of DK141967C publication Critical patent/DK141967C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK508077A 1976-11-16 1977-11-16 Analogifremgangsmaade til fremstilling af spirolactoner DK141967C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK454278A DK142951C (da) 1976-11-16 1978-10-12 Analogifremgangsmaade til fremstilling af spirolactoner

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2652761A DE2652761C2 (de) 1976-11-16 1976-11-16 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2652761 1976-11-16

Publications (3)

Publication Number Publication Date
DK508077A DK508077A (da) 1978-05-17
DK141967B DK141967B (da) 1980-07-28
DK141967C true DK141967C (da) 1980-12-08

Family

ID=5993550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK508077A DK141967C (da) 1976-11-16 1977-11-16 Analogifremgangsmaade til fremstilling af spirolactoner

Country Status (23)

Country Link
US (1) US4129564A (fr)
JP (2) JPS5363373A (fr)
AT (1) AT356827B (fr)
AU (1) AU512611B2 (fr)
BE (1) BE860877A (fr)
CA (1) CA1092094A (fr)
CH (2) CH631463A5 (fr)
CS (1) CS194823B2 (fr)
DD (1) DD132968B3 (fr)
DE (1) DE2652761C2 (fr)
DK (1) DK141967C (fr)
ES (1) ES464193A1 (fr)
FR (1) FR2370755A1 (fr)
GB (1) GB1550568A (fr)
GR (1) GR65227B (fr)
HU (1) HU174983B (fr)
IE (1) IE46076B1 (fr)
IL (1) IL53353A (fr)
IT (1) IT1092262B (fr)
LU (1) LU78514A1 (fr)
NL (1) NL7711946A (fr)
SE (1) SE436425B (fr)
SU (2) SU695560A3 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3022337A1 (de) * 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DE3051166C2 (en) * 1980-06-11 1990-10-18 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De Compsns. for contraception or treatment of gynaecological disorders
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3265852D1 (en) * 1981-09-21 1985-10-03 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE3213962A1 (de) * 1982-04-13 1983-10-13 Schering AG, 1000 Berlin und 4709 Bergkamen 1(alpha).2(alpha);6(beta).7(beta).15(beta).16(beta)-trimethylen-3-oxo-17(alpha)-pregn-4-en-21.17-carbolacton, dessen herstellung und verwendung als arzneimittel
DE3227598A1 (de) * 1982-07-22 1984-01-26 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-acylthio-15.16-methylen-3-oxo-17(alpha)-pregna-1.4-dien-21,17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3234972A1 (de) * 1982-09-17 1984-03-22 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-alkyl-17(alpha)-pregn-4-en-21.17-carbolactone und -21-carbonsaeuresalze sowie verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3240510A1 (de) * 1982-10-29 1984-05-03 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 7(alpha)-acylthio-1(alpha),2(alpha)-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, deren herstellung und diese enthaltende arzneimittel
JPS59139400A (ja) * 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3306554A1 (de) * 1983-02-22 1984-08-23 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-((delta)(pfeil hoch)4(pfeil hoch)-3-ketosteroid-17(alpha)-yl)-propionsaeurelactonen
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
EP0134529B1 (fr) * 1983-08-17 1990-03-21 Schering Aktiengesellschaft 3-Oxo-17-alpha-pregn-4-ene-21-17-carbolactone substituées en 7-alpha, procédé pour les préparer et compositions pharmaceutiques les contenant
DE3347510A1 (de) * 1983-12-27 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-oxo-17(alpha)-pregna-4,6-dien-21,17-carbolactonen
DE3402329A1 (de) * 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4670551A (en) * 1984-06-21 1987-06-02 Ciba-Geigy Corporation Epoxy steroids
JPS6248694A (ja) * 1985-08-28 1987-03-03 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
DE3544661A1 (de) * 1985-12-13 1987-06-19 Schering Ag Verfahren zur herstellung von 7(alpha)-acetylthiosteroiden
JPS62132932U (fr) * 1986-02-14 1987-08-21
US4837211A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Spironolactone composition
JPS6453026U (fr) * 1987-09-29 1989-03-31
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
EP0831911B1 (fr) * 1995-06-07 2002-04-17 G.D. Searle & Co. Therapie mixte a base de spironolactone et d'un antagoniste de l'angiotensine ii pour le traitement de l'insuffisance cardiaque globale
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
HUP0104249A3 (en) * 1998-11-06 2002-06-28 G D Searle & Co Chicago Pharmaceutical composition for combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
CA2382426C (fr) * 1999-08-31 2006-02-28 Schering Aktiengesellschaft Melange pharmaceutique d'ethinylestradiol et de drospirenone utilise en tant que contraceptif
DK1380301T3 (da) 1999-08-31 2009-04-20 Bayer Schering Pharma Ag Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
EP2305267A3 (fr) 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Combinaison pharmaceutique de l'éthinylestradiol et de la drospirénone pour utilisation comme contraceptif
DE60113809T2 (de) * 2000-01-18 2006-06-22 Schering Ag Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US6716829B2 (en) 2000-07-27 2004-04-06 Pharmacia Corporation Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
WO2002009683A2 (fr) * 2000-07-27 2002-02-07 Pharmacia Corporation Therapie anti-aldosterones destinee a prevenir ou traiter les troubles lies a une inflammation
EP1216712A1 (fr) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Complexes d'inclusion de drospirenone et de cyclodextrines
EP1216713A1 (fr) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions de complexes de estrogen-cyclodextrine
JP2004521951A (ja) * 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
KR20040107481A (ko) * 2002-03-18 2004-12-20 파마시아 코포레이션 알도스테론 수용체 길항물질 및 담즙산 격리제의 혼합물
WO2003080068A1 (fr) * 2002-03-18 2003-10-02 Pharmacia Corporation Combinaison d'antagoniste de recepteur d'aldosterone et d'acide nicotinique ou d'un derive d'acide nicotinique
ITMI20040367A1 (it) * 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
HUP0402465A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP2057182A2 (fr) * 2007-05-01 2009-05-13 Sicor, Inc. Procédé de préparation de la drospirénone et de produits intermédiaires de celle-ci
FR2917975B1 (fr) 2007-06-26 2009-10-16 Ceva Sante Animale Sa Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
US20090035373A1 (en) * 2007-07-31 2009-02-05 Katrin Mittmann Pharmaceutical composition for contraception and blood pressure regulation, kit for contraception containing same and method of production of same
US20090035374A1 (en) * 2007-07-31 2009-02-05 Katrin Mittmann Method of making a single-stage pharmaceutical preparation for oral therapy to regulate blood pressure and kit containing same
HUP0700826A3 (en) 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
EP2265629B1 (fr) * 2008-03-05 2015-06-24 Evestra, Inc. Carbolactones de bisméthylène-17 et utilisations associées
WO2010068500A2 (fr) * 2008-11-25 2010-06-17 Evestra, Inc. Γ-lactones d'acide 3-(6,6-éthylène-17β-hydroxy-3-oxo-17α-prégna-4-ène-17α-yl)propionique progestatives
WO2010094624A1 (fr) 2009-02-18 2010-08-26 Bayer Schering Pharma Aktiengesellschaft Particules comprenant de la drospirénone encapsulée dans un polymère
WO2010094623A1 (fr) 2009-02-18 2010-08-26 Bayer Schering Pharma Aktiengesellschaft Fo0rmulation comprenant de la drospirenone pour administration souscutanee ou intramusculaire
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) * 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
WO2011141456A1 (fr) 2010-05-10 2011-11-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés et compositions pour le traitement de l'accumulation de fluides dans et/ou sous la rétine
US9241944B2 (en) 2010-06-16 2016-01-26 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for stimulating reepithelialisation during wound healing
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
WO2016063269A1 (fr) 2014-10-20 2016-04-28 Prendergast Patrick T Utilisation d'antagonistes au récepteur stéroïdien nucléaire, seuls ou en association, comme agents antiviraux directs pour inhiber des alphavirus, togavirus, filovirus, arénavirus, bunyavirus, flavivirus et rhabdovirus
AU2016282863B2 (en) 2015-06-23 2021-05-27 Laboratorios Leon Farma Sa Drospirenone-based contraceptive for a female patient affected with excess weight
EP3108889A1 (fr) 2015-06-23 2016-12-28 Philippe Perrin Contraceptif à base de drospirenone pour un patient féminin ayant un excès de poids
WO2017055248A1 (fr) 2015-09-28 2017-04-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement d'une insuffisance cardiaque
ES2846835T3 (es) 2015-10-13 2021-07-29 Inst Nat Sante Rech Med Métodos y composiciones farmacéuticas para el tratamiento de la neovascularización coroidea
WO2018019843A1 (fr) 2016-07-26 2018-02-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistes du récepteur des minéralocorticoïdes pour le traitement de l'arthrose
EP4134082A1 (fr) 2021-08-12 2023-02-15 Chemo Research, S.L. Procédé de traitement de l'endométriose et de fourniture de contraception efficace
EP4395785A1 (fr) 2021-08-31 2024-07-10 Inserm (Institut National de la Santé et de la Recherche Scientifique) Méthodes de traitement de la rosacée oculaire
WO2023152658A1 (fr) 2022-02-10 2023-08-17 Lupin Limited Composition de comprimé de drospirénone à libération lente
WO2023165988A1 (fr) 2022-03-01 2023-09-07 Chemo Research, S.L. Contraceptif à administrer par voie orale par mastication

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257390A (en) * 1963-06-12 1966-06-21 Merck & Co Inc Ring a unsaturated 21-hydroxy-3-oxo-17alpha-pregnane-17-carboxylic acid lactone diuretic agents
NL166267C (nl) * 1968-03-22 1981-07-15 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten, de onder toepassing daarvan verkregen gevormde voort- brengselen, alsmede werkwijze ter bereiding van 6,7-methyleen-20-spirox-4-en-3-onderivaten met aldoste- ron remmende werking.
DE2237143A1 (de) * 1972-07-28 1974-02-14 Hoechst Ag Verfahren zur herstellung von beta(3-keto-7alpha-acetylthio-17beta-hydroxy4-androsten-17alpha-yl)-propionsaeuregamma-lacton und dessen 1-dehydro-derivat
CH601352A5 (fr) * 1973-09-26 1978-07-14 Hoffmann La Roche

Also Published As

Publication number Publication date
JPS61218595A (ja) 1986-09-29
DD132968A5 (de) 1978-11-22
IL53353A (en) 1982-04-30
IE46076B1 (en) 1983-02-09
GR65227B (en) 1980-07-30
FR2370755B1 (fr) 1980-06-06
SU695560A3 (ru) 1979-10-30
AU3050977A (en) 1979-05-17
JPH0242840B2 (fr) 1990-09-26
JPS6156240B2 (fr) 1986-12-01
CH631463A5 (de) 1982-08-13
SE436425B (sv) 1984-12-10
US4129564A (en) 1978-12-12
CS194823B2 (en) 1979-12-31
DK508077A (da) 1978-05-17
DD132968B3 (de) 1991-03-28
ES464193A1 (es) 1978-09-01
AT356827B (de) 1980-05-27
GB1550568A (en) 1979-08-15
FR2370755A1 (fr) 1978-06-09
CH632774A5 (de) 1982-10-29
DK141967B (da) 1980-07-28
IL53353A0 (en) 1978-01-31
ATA815577A (de) 1979-10-15
IE46076L (en) 1978-05-16
IT1092262B (it) 1985-07-06
LU78514A1 (fr) 1978-03-20
JPS5363373A (en) 1978-06-06
HU174983B (hu) 1980-04-28
SE7712891L (sv) 1978-05-17
DE2652761C2 (de) 1985-11-21
BE860877A (fr) 1978-05-16
SU743582A3 (ru) 1980-06-25
CA1092094A (fr) 1980-12-23
AU512611B2 (en) 1980-10-16
DE2652761A1 (de) 1978-05-18
NL7711946A (nl) 1978-05-18

Similar Documents

Publication Publication Date Title
DK141967C (da) Analogifremgangsmaade til fremstilling af spirolactoner
DK320977A (da) Fremgangsmade til fremstilling af bindemidler til elektrodyppelakering
DK30277A (da) Fremgangsmade til fremstilling af substituerede phenylamidiner
DK149062C (da) Analogifremgangsmaade til fremstilling af cefuroximestere
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK276177A (da) Fremgangsmade til fremstilling af gammapyron-forbindelser
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK154970C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK88777A (da) Fremgangsmade til fremstilling af substituerede azapuriner
DK271377A (da) Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK148684C (da) Analogifremgangsmaade til fremstilling af aryl-alkylaminer
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK582177A (da) Fremgangsmaade til fremstilling af halogenacylamider
DK123177A (da) Fremgangsmade til fremstilling af 7-alkoxy-3-chlormethyl-3-cephem-forbindelser
DK106677A (da) Fremgangsmade til fremstilling af 3-nethylencephalosporiner
DK301377A (da) Fremgangsmade til fremstilling af cishexahydrodibenzopyranoner
DK553077A (da) Fremgangsmaade til fremstilling af n-propylnorapomorphindiestere

Legal Events

Date Code Title Description
PBP Patent lapsed